secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nautilus Biotechnology, Inc. (NAUT)
CIK:        0001808805
Form:       8-K
Filed at:   2025-06-23T23:59:59+00:00
Accession:  0001808805-25-000054
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Nautilus Biotechnology elects Class I directors, ratifies PwC, reduces board size to 7
--------------------------------------------------------------------------------

- Sujal Patel re-elected with 84.3M votes for; Matthew McIlwain elected with 82.2M votes for.
- PricewaterhouseCoopers LLP ratified as auditor for 2025 with 99.5M votes for.
- Board reduced from 9 to 7 directors effective after annual meeting.
- Directors Vijay Pande and Michael Altman did not stand for re-election; McIlwain resigned as Class II to stand for Class I.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808805/000180880525000054/0001808805-25-000054-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808805/000180880525000054/naut-20250620.htm
  HTML page:      https://secwatch.observer/filing/0001808805-25-000054

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer